Back to search

Article

A Japanese single-center experience of the efficacy and safety of enzyme replacement therapy in childhood-onset hypophosphatasia

2021-08-03

Abstract excerpt

<title>Abstract</title> <p>BackgroundHypophosphatasia (HPP) is a rare inherited metabolic disorder caused by mutations in the ALPL gene, which encodes tissue nonspecific alkaline phosphatase. The phenotype of HPP is widely diverse from the perinatal severe form to the adult mild form. The former represents the most severe form and was earlier associated with high mortality due to impaired development of the lungs...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a459b573-8233-5466-a0e6-036ddfa81cdc
DOI
10.21203/rs.3.rs-718059/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Japanese single-center experience of the efficacy and safety of enzyme replacement therapy in childhood-onset hypophosphatasiaDOI 10.21203/rs.3.rs-718059/v1
Select a neighboring publication to make it the new centre.